http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_903f7dfa368dacb9d904d1b7a746f114
Outgoing Links
Predicate | Object |
---|---|
family-name | Beutler |
name | John A Beutler John A. Beutler |
given-name | John A. John A |
organization-name | Department of Chemistry, University of Iowa, Iowa City, Iowa 52242-1294, and Molecular Targets Development Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702 College of Pharmacy, Chungnam National University, Daejeon 305-764, Korea, and Molecular Targets Development Program, HIV Drug Resistance Program, and SAIC-Frederick, National Cancer Institute, Building 1052, Frederick Maryland 21702 a SAIC Frederick, National Cancer Institute-Frederick Cancer Research and Development Center , Frederick , MD , 21702 Natural Products Support Group, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland 21702, Laboratory of Proteomics and Analytical Technologies, Advanced Technology Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland 21702, Molecular Targets Laboratory, Center for Cancer Research, NCI-Frederick, Frederick, Maryland 21702, and Bioresources Development and Conservation Programme-Cameroon, Yaounde, Cameroon Molecular Targets Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States Molecular Targets Laboratory, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland 21702, United States Laboratory of Drug Discovery Research and Development, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, Maryland 21702-1201 Molecular Targets Program, Center for Cancer Research National Cancer Institute Frederick Maryland Molecular Targets Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702-1201, United States Molecular Targets Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland 21702 Molecular Targets Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States Laboratory of Cancer Prevention and Molecular Targets Laboratory, Center for Cancer Research, NCI-Frederick, Frederick, Maryland 21702, United States Laboratory of Drug Discovery Research and Development, Developmental Therapeutics Program, Division of Cancer Treatment, Diagnosis, and Centers, National Cancer Institute-FCRDC, Building 1052, Room 121, Frederick, Maryland 21702-1201 Authors' Affiliations: 1Molecular Targets Development Program and 2Mouse Cancer Genetics Program, Center for Cancer Research, and 3Optical Microscopy and Image Analysis Laboratory SAIC-Frederick, NCI-Frederick, Frederick, Maryland; and 4Department of Chemistry, University of Iowa, Iowa City, Iowa Laboratory of Drug Discovery Research and Development, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute−Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201 Molecular Targets Program, Center for Cancer Research National Cancer Institute Frederick MD USA Molecular Targets Development Program, Center for Cancer Research, and Screening Technologies Branch, Developmental Therapeutics Program, National Cancer Institute, NCI—Frederick, Frederick, Maryland 21702 Molecular Targets Development Program and Laboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, Department of Biochemistry, McGill University, Montreal, QC, Canada H3G 1Y6, and Data Management Services, Inc. and Basic Research Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland 21702 National Cancer Institute Frederick Maryland Molecular Targets Program, National Cancer Institute—Frederick, Frederick Maryland 21702 Molecular Targets Laboratory, Center for Cancer Research, National Cancer Institute, Boulevard, Dallas, TX 75390, USA Molecular Targets Laboratory; Center for Cancer Research; National Cancer Institute at Frederick; Frederick; USA Laboratory of Drug Discovery Research & Development, Developmental Therapeutics Program, Division of Cancer Treatment & Diagnosis, National Cancer Institute−FCRDC, Bldg. 1052, Rm. 121, Frederick, Maryland 21702-1201 Molecular Targets Development Program, Center for Cancer Research, National Cancer Institute, Building 1052, Room 121, Frederick, Maryland 21702-1201 Molecular Targets Development Program, Center for Cancer Research, National Cancer Institute—Frederick, Frederick, Maryland Molecular Targets Laboratory, Center for Cancer Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States 3Molecular Targets Development Program, Center for Cancer Research, National Cancer Institute at Frederick, NIH, Frederick, Maryland; Molecular Targets Drug Discovery Program, Center for Cancer Research, National Cancer Institute, Building 1052, Room 121, Frederick, Maryland 21702-1201 Laboratory of Drug Discovery Research and Development, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute−Frederick Cancer Research and Development Center, Building 1052, Room 121, Maryland 21702-1201, SAIC−Frederick, Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201, and Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland 20892-0805 Molecular Targets Laboratory, Molecular Discovery Program, National Cancer Institute, Frederick, Maryland 21702, United States Department of Chemistry and Center for Chemical Methodology and Library Development (CMLD-BU), Boston University, 590 Commonwealth Avenue, Boston, Massachusetts 02215, and Molecular Targets Development Program, National Cancer Institute at Frederick, Building 560-15, Frederick, Maryland 21702 Molecular Targets Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA Molecular Targets Development Program, SAIC-Frederick, Inc., and HIV Drug Resistance Program, NCI-Frederick, Frederick, Maryland 21702 Laboratory of Drug Discovery Research and Development, Developmental Therapeutics Program, Division of Cancer Treatment, Diagnosis and Centers, NCI−Frederick Cancer Research and Development Center, Building 1052, Room 121, Frederick, Maryland 21702-1201, AIDS Vaccine Program, SAIC, NCI−Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201, and Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, Building 8, Room B2A23, Bethesda,... Molecular Discovery Program, National Cancer Institute—Frederick, Frederick, Maryland 21702, United States Molecular Targets Laboratory, National Cancer Institute, Frederick, Maryland 21702, United States Molecular Targets Program, National Cancer Institute, Frederick, Maryland, USA Molecular Targets Laboratory, Center for Cancer Research, NCI-Frederick, Frederick, Maryland 21702-1124, United States Laboratory of Medicinal Plant Science, School of Pharmacy, Tokyo University of Pharmacy and Life Science, 1432-1, Horinouchi, Hachioji, Tokyo 192-0392, Japan, and Laboratory of Drug Discovery Research & Development, Developmental Therapeutics Program Division of Cancer Treatment, Diagnosis and Centers, National Cancer Institute, Bldg. 1052, National Cancer Institute-Frederick Cancer Research Center, Frederick, Maryland 21702-1201 Molecular Targets Laboratory, Molecular Discovery Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States Molecular Targets Laboratory, National Cancer Institute, Frederick, MD |
Incoming Links
Total number of triples: 162.